$Age, creatinine clearance, and ejection fraction (mACEF) score predicts long-term cardiac mortality in patients with hypertrophic obstructive cardiomyopathy treated non-invasively$
Código QR

Código QR

Age, creatinine clearance, and ejection fraction (mACEF) score predicts long-term cardiac mortality in patients with hypertrophic obstructive cardiomyopathy treated non-invasively

Guardado en:

Detalles Bibliográficos
Autores principales:	Jun Gao, Chunli Shao, Wenyao Wang, Xiangbin Meng, Kuo Zhang, Jingjia Wang, Mingqi Zheng, Yi-Da Tang
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/00113b19d4bf4932bfd5312248a44b81
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
por: Maike Schuldt, et al.
Publicado: (2021)

Clinical predictors of the presence of obstructive sleep apnea in patients with hypertrophic cardiomyopathy
por: Haobo Xu, et al.
Publicado: (2021)

Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014)

Relationship Between Obstructive Sleep Apnea and Late Gadolinium Enhancement and Their Effect on Cardiac Arrhythmias in Patients with Hypertrophic Obstructive Cardiomyopathy
por: Wang S, et al.
Publicado: (2021)

The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
por: Martino Deidda, et al.
Publicado: (2021)

Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction
por: Yumin Li, et al.
Publicado: (2021)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Qiang Liu, et al.
Publicado: (2021)

Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy
por: Li-Min Liu, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy with a Twist
por: W. Francis, et al.
Publicado: (2021)

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy
por: Sarinya Puwanant, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy in South Western Nigeria
por: Amam Mbakwem, et al.
Publicado: (2017)

Feline hypertrophic cardiomyopathy: an echocardiographic approach
por: Silva,AC, et al.
Publicado: (2013)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Milla E. Arabadjian, et al.
Publicado: (2021)

Efficacy and safety of alcohol septal ablation in patients over 65 years old with obstructive hypertrophic cardiomyopathy
por: Cheddadi L, et al.
Publicado: (2017)

Sex differences in the prognosis of patients with hypertrophic cardiomyopathy
por: Minkwan Kim, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy: a modern view of the problem
por: Amina M. Alieva, et al.
Publicado: (2020)

Predictive value of the age, creatinine and ejection fraction score in patients undergoing primary percutaneous coronary intervention with bail-out tirofiban therapy
por: Altuğ Ösken, et al.
Publicado: (2021)

Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
por: Milind Y. Desai, et al.
Publicado: (2021)

Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy
por: Umut Karabulut, et al.
Publicado: (2021)

Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China
por: Shuo-yan An, et al.
Publicado: (2017)

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
por: Styliani Vakrou, et al.
Publicado: (2021)

Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
por: Elena V. Filatova, et al.
Publicado: (2021)

CREATININE CLEARANCE AS EFFECTIVE NON-INVASIVE MARKER IN DETERMINING GASTROINTESTINAL LESIONS AND HELICOBACTER PYLORI INFECTION
por: Zubia Jamil, et al.
Publicado: (2018)

Atrioventricular nodal ablation and left bundle branch pacing for treatment of refractory atrial fibrillation post alcohol septal ablation for hypertrophic obstructive cardiomyopathy
por: Rory Gallen, MB, BcH, BAO, et al.
Publicado: (2021)

Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy
por: Maria Calderon-Dominguez, et al.
Publicado: (2021)

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Nancy Luo, MD, MHS, et al.
Publicado: (2021)

Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy
por: Dimitrios Ntelios, et al.
Publicado: (2021)

Identification of key proteins and lncRNAs in hypertrophic cardiomyopathy by integrated network analysis
por: Xiaofeng Hu, et al.
Publicado: (2019)

Left ventricular non-compaction with hypertrophic cardiomyopathy, a mutually beneficial combination?
por: Vijayaraghavan Govindan, et al.
Publicado: (2021)

Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Pratch Sukumolanan, et al.
Publicado: (2021)

A retrospective study comparing creatinine clearance estimation using different equations on a population-based cohort
por: Abigail Ferreira, et al.
Publicado: (2021)

Prevalence, functional characteristics, and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy
por: Jiwon Seo, et al.
Publicado: (2020)

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Bradley A. Maron, et al.
Publicado: (2021)

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
por: Arjun S. Adhikari, et al.
Publicado: (2019)

Loss of embryonic neural crest derived cardiomyocytes causes adult onset hypertrophic cardiomyopathy in zebrafish
por: Sarah Abdul-Wajid, et al.
Publicado: (2018)

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
por: Julien Robert-Paganin, et al.
Publicado: (2018)

Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging
por: Mateusz Śpiewak, et al.
Publicado: (2021)

Homeostatic Left Heart integration and disintegration links atrio-ventricular covariation’s dyshomeostasis in Hypertrophic Cardiomyopathy
por: Paolo Piras, et al.
Publicado: (2017)

Conduction abnormalities post alcohol septal ablation for hypertrophic cardiomyopathy – A single center experience
por: Avinash Mani, et al.
Publicado: (2021)

A genetic polymorphism in P2RY 1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy
por: Yu Ueda, et al.
Publicado: (2021)